Table 1.
Patient demographics, covariates, and treatment outcome in children with uncomplicated falciparum malaria in Burkina Faso
| Total no. of patients | 236 |
|---|---|
| Total no. of samples/patient | 10.0 (3.00–11.0) |
| Total dose of piperaquine tetra-phosphate (mg/kg) |
56.5 (45.0–72.0) |
| Total dose of piperaquine base (mg/kg) | 32.6 (26.1–41.6) |
| Total dose of dihydroartemisinin (mg/kg) | 7.06 (5.65–9.00) |
| Continuous and categorical covariates | |
| Age (years) | 6 (2–10) |
| Body weight (kg) | 18 (8–34) |
| Axillary temperature at admission (°C) | 38.7 (36–41) |
| Parasitemia at admission (no. of parasites/μl) | 30,400 (2,000–199,000) |
| Hemoglobin at admission (g/l) | 10.6 (5.00–15.0) |
| Males (%) | 131 (55.5%) |
| Treatment outcomea | |
| No. of patients with no parasitemia reappearance (%) |
204 (86.4%) |
| No. of patients with recrudescence (%) | 2 (0.85%) |
| Time (days) to recrudescence | 28 (21–35) |
| No. of patients with new infection (%) | 25 (10.6%) |
| Time (days) to new infection | 39 (28–42) |
| No. of patients lost during follow-up (%) | 5 (2.12%) |
| Time (days) to lost | 7 (4–14) |
All values are given as median (range) unless otherwise specified.
a
As confirmed by PCR.